Role of LOX-1 (lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use

J Barreto, SK Karathanasis, A Remaley… - … , and vascular biology, 2021 - Am Heart Assoc
Atherosclerosis, the underlying cause of cardiovascular disease (CVD), is a worldwide
cause of morbidity and mortality. Reducing ApoB-containing lipoproteins—chiefly, LDL (low …

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease

A Akhmedov, T Sawamura, CH Chen… - European heart …, 2021 - academic.oup.com
Cardiovascular diseases (CVDs), specifically lipid-driven atherosclerotic CVDs, remain the
number one cause of death worldwide. The lectin-like oxidized low-density lipoprotein (LDL) …

LOX-1 receptor: A potential link in atherosclerosis and cancer

S Balzan, V Lubrano - Life sciences, 2018 - Elsevier
Altered production of reactive oxygen species (ROS), causing lipid peroxidation and DNA
damage, contributes to the progression of atherosclerosis and cancer. Lectin-like oxidized …

The mannose receptor: from endocytic receptor and biomarker to regulator of (meta) inflammation

HJP van der Zande, D Nitsche, L Schlautmann… - Frontiers in …, 2021 - frontiersin.org
The mannose receptor is a member of the C-type lectin (CLEC) family, which can bind and
internalize a variety of endogenous and pathogen-associated ligands. Because of these …

Cholesterol and the journey of extracellular vesicles

F Pfrieger, N Vitale - Journal of lipid research, 2018 - hal.science
Eukaryotic cells employ distinct means to release specific signals and material. Research
within the last decade has identified different types of membrane-enclosed structures …

Soluble LOX‐1: a novel biomarker in patients with coronary artery disease, stroke, and acute aortic dissection?

A Hofmann, C Brunssen, S Wolk, C Reeps… - Journal of the …, 2020 - Am Heart Assoc
Cardiovascular diseases are the leading cause of death worldwide. Approximately 85% of
all deaths from cardiovascular disease are due to acute myocardial infarction (AMI) and …

Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases

A Hofmann, C Brunssen, H Morawietz - Vascular pharmacology, 2018 - Elsevier
The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is the major receptor for
binding and uptake of oxidized low-density lipoprotein (oxLDL) in endothelial cells. LOX-1 is …

Unraveling the intricate roles of exosomes in cardiovascular diseases: A comprehensive review of physiological significance and pathological implications

S Zhang, Y Yang, X Lv, W Liu, S Zhu, Y Wang… - International Journal of …, 2023 - mdpi.com
Exosomes, as potent intercellular communication tools, have garnered significant attention
due to their unique cargo-carrying capabilities, which enable them to influence diverse …

Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology–A new chance for causative therapy?

J Groner, A Goepferich, M Breunig - Journal of Controlled Release, 2021 - Elsevier
Atherosclerosis is the leading cause of death in developed countries. The pathogenetic
mechanism relies on a macrophage-based immune reaction to low density lipoprotein (LDL) …

[HTML][HTML] Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review

JPR Cruz Neto, MO de Luna Freire… - Foods, 2024 - mdpi.com
Atherosclerosis (AS) is a chronic inflammatory vascular disease. Dysregulated lipid
metabolism, oxidative stress, and inflammation are the major mechanisms implicated in the …